These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 25917525

  • 1. An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs.
    Borgheti-Cardoso LN, Depieri LV, Kooijmans SA, Diniz H, Calzzani RA, Vicentini FT, van der Meel R, Fantini MC, Iyomasa MM, Schiffelers RM, Bentley MV.
    Eur J Pharm Sci; 2015 Jul 10; 74():103-17. PubMed ID: 25917525
    [Abstract] [Full Text] [Related]

  • 2. Self-assembling gelling formulation based on a crystalline-phase liquid as a non-viral vector for siRNA delivery.
    Borgheti-Cardoso LN, Depieri LV, Diniz H, Calzzani RA, de Abreu Fantini MC, Iyomasa MM, Moura de Carvalho Vicentini FT, Bentley MV.
    Eur J Pharm Sci; 2014 Jul 16; 58():72-82. PubMed ID: 24726985
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Monoglyceride Content Affects the Self-Assembly Behavior, Rheological Properties, Syringeability, and Mucoadhesion of In Situ-Gelling Liquid Crystalline Phase.
    Nunes KM, Teixeira CC, Kaminski RC, Sarmento VH, Couto RO, Pulcinelli SH, Freitas O.
    J Pharm Sci; 2016 Aug 16; 105(8):2355-64. PubMed ID: 27339408
    [Abstract] [Full Text] [Related]

  • 6. In situ gelling hexagonal phases for sustained release of an anti-addiction drug.
    Phelps J, Bentley MV, Lopes LB.
    Colloids Surf B Biointerfaces; 2011 Oct 15; 87(2):391-8. PubMed ID: 21703826
    [Abstract] [Full Text] [Related]

  • 7. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A, Merkel O, Fink L, Czubayko F, Kissel T, Aigner A.
    Toxicol Appl Pharmacol; 2009 Apr 01; 236(1):97-108. PubMed ID: 19371615
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase.
    Depieri LV, Borgheti-Cardoso LN, Campos PM, Otaguiri KK, Vicentini FT, Lopes LB, Fonseca MJ, Bentley MV.
    Eur J Pharm Biopharm; 2016 Aug 01; 105():50-8. PubMed ID: 27224855
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
    Petrilli R, Eloy JO, Praça FS, Del Ciampo JO, Fantini MA, Fonseca MJ, Bentley MV.
    J Biomed Nanotechnol; 2016 May 01; 12(5):1063-75. PubMed ID: 27305826
    [Abstract] [Full Text] [Related]

  • 13. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A, Höbel S, Heine C, Merz L, Kallendrusch S, Bechmann I, Merz F, Franke H, Aigner A.
    Drug Deliv Transl Res; 2017 Apr 01; 7(2):206-216. PubMed ID: 27334279
    [Abstract] [Full Text] [Related]

  • 14. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW, Xiang B, Gao W, Yang ZZ, Li JQ, Qi XR.
    Biomaterials; 2013 Jul 01; 34(20):4849-59. PubMed ID: 23541420
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases.
    Réeff J, Gaignaux A, Goole J, De Vriese C, Amighi K.
    Drug Dev Ind Pharm; 2013 Nov 01; 39(11):1731-41. PubMed ID: 23078519
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.